arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 11/2021 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Reduce the mighty carbon dioxide footprint of pressurized metered-dose inhaler … 1 metered-dose inhaler is equivalent to a 280 km car trip

    NEW ON THE MARKET

    New indication: upadacitinib (RINVOQ) for atopic dermatitis

    Ofatumumab (KESIMPTA) in multiple sclerosis

    THERAPY FROM A CRITICAL VIEWPOINT

    Duration of platelet inhibition after percutaneous coronary intervention (PCI) in patients at high bleeding risk

    a-t READERS QUESTIONS AND COMMENTS

    Cannabidiol against osteoarthritis pain?

    IN BRIEF

    Dapagliflozin (FORXIGA) no longer approved for type I diabetes
    free

    SIDE EFFECTS

    Myocarditis: Moderna vaccine no longer for people under 30 years of age

    RAYNAUD syndrome with antibodies used for the prevention of migraine

    Information on drug-induced QT prolongation is unsatisfactory

    e a-t ON THE INTERNET

    New indication: upadacitinib (RINVOQ) for atopic dermatitis (long version)

    Ofatumumab (KESIMPTA) in multiple sclerosis (long version)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!